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Little	is	known	about	whether	bone	marrow–derived	circulating	progenitor	cells	(BMDCPCs)	can	transdif-
ferentiate	into	adipocytes	in	adipose	tissues	or	play	a	role	in	expanding	adipocyte	number	during	adipose	
tissue	growth.	Using	a	mouse	bone	marrow	transplantation	model,	we	addressed	whether	BMDCPCs	can	
transdifferentiate	into	adipocytes	under	standard	conditions	as	well	as	in	the	settings	of	diet-induced	obesity,	
rosiglitazone	treatment,	and	exposure	to	G-CSF.	We	also	addressed	the	possibility	of	transdifferentiation	to	
adipocytes	in	a	murine	parabiosis	model.	In	each	of	these	settings,	our	findings	indicated	that	BMDCPCs	did	
not	transdifferentiate	into	either	unilocular	or	multilocular	adipocytes	in	adipose	tissues.	Most	BMDCPCs	
became	resident	and	phagocytic	macrophages	in	adipose	tissues	—	which	resembled	transdifferentiated	mul-
tilocular	adipocytes	by	appearance,	but	displayed	cell	surface	markers	characteristic	for	macrophages	—	in	
the	absence	of	adipocyte	marker	expression.	When	exposed	to	adipogenic	medium	in	vitro,	bone	marrow	cells	
differentiated	into	multilocular,	but	not	unilocular,	adipocytes,	but	transdifferentiation	was	not	observed	in	
vivo,	even	in	the	contexts	of	adipose	tissue	regrowth	or	dermal	wound	healing.	Our	results	suggest	that	BMD-
CPCs	do	not	transdifferentiate	into	adipocytes	in	vivo	and	play	little,	if	any,	role	in	expanding	the	number	of	
adipocytes	during	the	growth	of	adipose	tissues.
Introduction
Balanced growth of adipose tissues is necessary for energy homeo-
stasis, insulation of heat loss, and mechanical support for other 
structures in the body. However, excess adipose tissue is defined as 
obesity and is associated with metabolic syndrome (1, 2). Growth 
of adipose tissues mainly results from an increase in the number 
and size of adipocytes (3, 4). During embryonic development, 
some mesenchymal stem cells differentiate into adipoblasts that 
eventually become preadipocytes. These preadipocytes become 
unilocular, lipid-laden mature adipocytes by appropriate stimu-
lation during postnatal development. This sequential differentia-
tion process from mesenchymal stem cells to mature adipocytes 
is termed adipogenesis (5). In comparison, under a higher level of 
energy homeostasis, mature adipocytes become bigger adipocytes 
with an unilocular accumulation of lipid, a process known as lipo-
genesis (6). Adipogenesis is the predominant process in the normal 
development of adipose tissues after birth, while lipogenesis is 
the predominant process in the development of obesity involving 
adult adipose tissues. These 2 fundamental processes have been 
thought to mainly occur in the resident adipoblasts, preadipo-
cytes, and adipocytes within each area of adipose tissue, although 
there is a lack of clear evidence that this is so.
Adult white adipose tissue is mainly composed of mature uni-
locular (i.e., comprising a single lipid compartment surrounded 
by perilipin) adipocytes, which are supported by stromal vascu-
lar tissue containing vascular endothelial cells and macrophages, 
and poorly characterized undifferentiated or stem cells containing 
adipoblasts, preadipocytes, fibroblasts, and hematopoietic cells 
(7–11). Obviously, the sizes, shapes, numbers, and even roles of 
these cells are variable depending on their localization and situ-
ation during overgrowth of adipose tissues, i.e., obesity (12, 13). 
In obesity, a size increase in adipocytes is a common and evident 
phenomenon. Rodents fed a high-fat diet from adulthood display 
abnormal overgrowth of adipose tissues with variable increases in 
adipocyte size, a consequence of lipogenesis. This manifestation is 
followed by variable increases in the number of adipocytes, a con-
sequence of proliferation of resident adipoblasts/preadipocytes (3, 
4, 14). However, it is still not known whether these resident adipo-
blasts and preadipocytes are derived from mesenchymal cells with-
in adipose tissue (9) or from bone marrow stem cells outside of 
adipose tissue through circulation and recruitment as bone mar-
row–derived circulating progenitor cells (BMDCPCs). Moreover, 
because there are still no specific molecular markers to distinguish 
adipoblasts and preadipocytes from differentiated adipocytes and 
nonadipocytes in the adult adipose tissue, the underlying mecha-
nisms of how the number of adipocytes increases during adipose 
tissue growth remains to be elucidated.
BMDCPCs originate from hematopoietic stem cells and 
mesenchymal stem cells in the bone marrow and are mobilized 
from bone marrow to systemic circulation under appropriate 
stimuli. These BMDCPCs become resident cells in every organ, 
Nonstandard	abbreviations	used: BMDCPC, bone marrow–derived circulating 
progenitor cell; BMT, bone marrow transplantation; DPBS, Dulbecco’s PBS; LYVE-1, 
lymph vessel endothelial hyaluronan receptor-1; ROSI, rosiglitazone; SVC, stromal 
vascular cell.
Conflict	of	interest: The authors have declared that no conflict of interest exists.
Citation	for	this	article: J. Clin. Invest. 117:3684–3695 (2007). doi:10.1172/JCI32504.
  Related Commentary, page 3653
research article
	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 117   Number 12   December 2007 3685
variously as differentiated or transdifferentiated cells depending 
on the local tissue microenvironment (15–23). However, whether 
BMDCPCs can transdifferentiate into mature adipocytes in adult 
adipose tissues has not been well established. Moreover, it is 
unknown whether BMDCPCs play a significant role in expand-
ing the number of adipocytes in the growth of adipose tissues. 
Therefore, in this study, we investigated whether BMDCPCs can 
transdifferentiate into adipocytes in normal and obese adipose 
tissues. To do so, we used visualization and characterization of 
GFP+ cells in the several adipose tissues of the adult mice that had 
received bone marrow transplantation (BMT) with donor bone 
marrow cells from transgenic mice expressing enhanced GFP on a 
universal promoter (24). We also questioned whether BMDCPCs 
can transdifferentiate into adipocytes in the regrowing adipose tis-
sue and in wound-healing dermal tissue. To clearly visualize and 
characterize GFP+ BMDCPCs in the multicellular adipose tissues, 
whole-mounted adipose tissues were immunostained for markers 
of adipocytes, macrophages, and extracellular matrix protein.
Our results with rigorous confocal microscopic analysis revealed 
that BMDCPCs did not transdifferentiate into unilocular or mul-
tilocular adipocytes in normal, obese, or regrowing adipose tissues. 
During preparation of this article, Crossno et al. (25) reported that 
BMDCPCs can transdifferentiate into multilocular, but not uni-
locular, adipocytes in the adipose tissues. Given these different 
Figure 1
No GFP+perilipin+ adipocytes were detected in the adipose tissues of mice fed a normal diet. Adipose tissues were harvested from C57BL/6J 
mice that had received BMT from GFP+ mice 2 months previously and then fed a normal diet for the 2-month period. Tissues were whole-mount-
ed, coimmunostained for perilipin (adipocytes; red stain) and PECAM-1 or CD11b (blood vessels or macrophages, respectively; blue stain), 
and merged. No GFP+ cells (green stain) were perilipin+ adipocytes in the adipose tissues; approximately half of the GFP+ cells were CD11b+ 
macrophages in the adipose tissues. Scale bars: 100 μm.
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findings, we discuss our results in the context of the similarities 
and dissimilarities between these 2 studies.
Results
BMDCPCs do not transdifferentiate into adipocytes in adult adipose tissues 
under normal or obese conditions. To investigate the possibility of a 
commitment of BMDCPCs to transdifferentiate into adipocytes 
in adult adipose tissues, we examined the adipose tissues of BMT 
mice transplanted 2 months previously with GFP+ bone marrow 
cells. To detect GFP+ adipocytes in the adipose tissues, the whole-
mounted adipose tissues were coimmunostained for perilipin 
(a membrane protein that surrounds lipid droplets and is selec-
tively expressed in adipocytes and steroidogenic cells; refs. 26, 27), 
adipophilin (known as adipose differentiation-related protein; a 
membrane protein that surrounds small lipid droplets and is 
expressed ubiquitously; refs. 26–28) and CD11b (a specific marker 
of monocytes/macrophages) or PECAM-1 (a specific component 
of vascular endothelial cells). Our analysis revealed that none of the 
GFP+ cells were perilipin+ adipocytes in epididymal (~50,000 adipo-
cytes), mesenteric (~30,000 adipocytes), retroperitoneal (~20,000 
adipocytes), subcutaneous (~50,000 adipocytes), or dermal (~5,000 
adipocytes) adipose tissues of the normal diet–fed mice (n = 5; Fig-
ure 1 and Supplemental Figure 1A; supplemental material avail-
able online with this article; doi:10.1172/JCI32504DS1). Moreover, 
none of the GFP+ cells were adipophilin+ adipocytes in epididy-
mal (~2,500 adipocytes) or retroperitoneal (~1,000 adipocytes) 
adipose tissues of the normal diet–fed mice (n = 3; Supplemental 
Figures 1B and 2A). Most GFP+ cells were CD11b+, F4/80+, lymph 
vessel endothelial hyaluronan receptor–1–positive (LYVE-1+), 
or CD45+ macrophages in the adipose tissues (Figure 1 and Sup-
plemental Figure 3). In comparison, bone marrow–derived GFP+ 
cells were largely detected as macrophages or leukocytes in several 
organs including spleen, kidney, lung, intestinal villi, liver, tracheal 
mucosa, and retina (Supplemental Figure 4). Sometimes, groups 
of GFP+ cells were detected, but a dissecting image analysis of these 
cells by confocal microscopy revealed that these cells clearly were 
not GFP+ adipocytes (Supplemental Figure 5).
To examine the commitment, if any, of BMDCPCs to transdif-
ferentiate into adipocytes of adult adipose tissues during obesity, 
the BMT mice that had received GFP+ bone marrow cells 2 months 
previously were fed with a high-fat diet containing 34.9% (wt/wt) 
fat for the 2 months following BMT. The high-fat diet–fed mice 
displayed an approximately 1.4-fold increase in body weight, an 
approximately 2.2-fold increase in epididymal adipose tissue 
weight, and an approximately 2.0-fold increase in the diameter of 
adipocytes in epididymal adipose tissue compared with mice fed 
normal diet (Figure 2 and Supplemental Figure 6). Nevertheless, 
our analysis revealed that none of the GFP+ cells were perilipin+ adi-
pocytes in epididymal (~50,000 adipocytes), mesenteric (~30,000 
adipocytes), retroperitoneal (~20,000 adipocytes), subcutaneous 
(~50,000 adipocytes), or dermal (~5,000 adipocytes) adipose tissues 
of the high-fat diet–fed mice (n = 5; Figure 2 and Supplemental Fig-
ure 1C). Moreover, none of the GFP+ cells were adipophilin+ adipo-
cytes in epididymal (~2,500 adipocytes) or retroperitoneal (~1,000 
adipocytes) adipose tissues of the high-fat diet–fed mice (n = 3; 
Supplemental Figure 2B). Most of the GFP+ cells were small, singu-
lar nonadipocytes in the adipose tissues (Figure 2). Several (~750 
of 155,000 adipocytes) GFP+ cells that were similar to unilocular 
adipocytes were detected (Figure 2, A and B); however, a dissecting 
image analysis of these cells by confocal microscopy revealed that 
these cells were not GFP+ unilocular adipocytes but instead were 
clustered GFP+ cells (Figure 2C). In fact, most of these cells were 
F4/80+ macrophages (~85%; Figure 3, A–C), and to a lesser extent, 
CD11b+ macrophages (~26%) or CD45+ macrophages (~34%; Fig-
ure 3, A and B). However, these cells contained a negligible number 
of LYVE-1+ macrophages (~4%; Figure 3, A and B). Thus, our results 
indicate that BMDCPCs do not transdifferentiate into adipocytes 
in adult adipose tissues under normal or obese conditions.
Figure 2
No GFP+perilipin+ adipocytes were detected in the adi-
pose tissues of mice fed a high-fat diet. Adipose tissues 
were harvested from C57BL/6J mice that had received 
BMT from GFP+ mice 2 months previously and then were 
fed a high-fat diet for the 2-month period. Tissues were 
whole-mounted, coimmunostained for perilipin (red stain) 
and PECAM-1 (blue stain), and merged. The sizes of adi-
pocytes were approximately twice that of adipocytes from 
the mice fed the normal diet. (A–C) In epididymal fat (EF), 
some larger GFP+ cells (green stain) looked like unilocular 
adipocytes (A and B, boxed regions), but sequential dis-
sected images of this portion (boxed region in B) revealed 
clustered GFP+perilipin– smaller cells (C). (D) Mesenteric 
fat (MF). (E) Retroperitoneal fat (RF). (F) Subcutaneous 
fat (SF). (G and H) Dermal fat of ear skin (DF); H shows a 
higher-magnification view of boxed region in G. No GFP+ 
cells were perilipin+ adipocytes in the adipose tissues. 
Scale bars: 100 μm.
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BMDCPCs do not transdifferentiate into unilocular or multilocular adi-
pocytes in adult adipose tissues in normal or obese conditions. Because a 
recent study (25) reported that high-fat diet–induced obesity pro-
moted transdifferentiation of BMDCPCs into multilocular adipo-
cytes in the adipose tissues, with a range of about 7%–17% of total 
adipocytes, we determined whether GFP+perilipin+ multilocular 
adipocytes were formed in the normal and high-fat diet–induced 
obese adipose tissues. To distinguish multilocular adipocytes from 
unilocular adipocytes in adult adipose, the whole-mounted adi-
pose tissues were coimmunostained for perilipin and collagen IV, 
which surrounds each adipocyte individually as a basement 
membrane (29). This coimmunostaining clearly distinguished 
not only collagen IV–covered adipocytes from nonadipocytes, 
but also multilocular adipocytes from unilocular adipocytes 
(Figure 4). Compared with the adipose tissues of normal diet–fed 
mice, the adipose tissues from mice consuming a high-fat diet 
for 2 months did not exhibit a significant change in the extent of 
multilocularization of adipocytes. In both normal and high-fat 
diet–induced obese mice, the population frequency of multilocu-
lar adipocytes in white adipose tissues was as follows, arranged in 
descending order of frequency: mesenteric (25%–27%), retroperi-
toneal (20%–23%), dermal (11%–14%), subcutaneous (8%–10%), 
epididymal (3%–4%). In comparison, most of the adipocytes in 
the intersubscapular brown adipose tissues were multilocular 
adipocytes in both groups. Nevertheless, in contrast to the report 
of Crossno et al. (25), none of the GFP+ cells were perilipin+ mul-
tilocular adipocytes in epididymal (~12,000 adipocytes), mesen-
teric (~24,000 adipocytes), retroperitoneal (~24,000 adipocytes), 
subcutaneous (~18,000 adipocytes), or dermal (~3,000 adipo-
cytes) adipose tissues of the normal and high-fat diet–induced 
obese mice (n = 3 per group; Figure 4). In the obese mice, there 
were 2 kinds of clustered GFP+ cells, GFP+perilipin–collagen IV+ 
and GFP+perilipin–collagen IV– (Figure 4B), which suggested 
that degradation of perilipin by phagocytic macrophages pre-
cedes degradation of collagen IV. In comparison, in the inter-
subscapular brown adipose tissue of the normal and obese mice, 
none of the GFP+ cells were perilipin+ multilocular adipocytes 
(~6,000 adipocytes; n = 3 per group; Figure 4). It is interesting to 
Figure 3
Clustered GFP+ cells in the adipose tissue of mice fed the high-fat diet were F4/80+ macrophages. (A) Epididymal adipose tissue was harvested 
from C57BL/6J mice that had received BMT from GFP+ mice 2 months previously and then were fed a high-fat diet for the 2-month period. Tis-
sues were whole-mounted; coimmunostained for perilipin (red stain) and the macrophage markers CD11b, F4/80, LYVE-1, or CD45 (blue stain); 
and merged. Note that most of the clustered GFP+ cells (green stain) were F4/80+ macrophages, and to a lesser extent, these were CD11b+ or 
CD45+ macrophages. Scale bar: 100 μm. (B) GFP+CD11b+, GFP+F4/80+, GFP+LYVE-1+, and GFP+CD45+ macrophages were counted in 30 
regions of clustered GFP+ cells (~3,000) and presented as a percentage of the total counted, clustered GFP+ cells. (C) Higher-magnification 
view of the merged GFP-, perilipin-, and F4/80-stained (green, red, and blue stain, respectively) image in A revealed characteristic GFP+F4/80+ 
clustered macrophages. Scale bars: 50 μm.
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note that the clustered GFP+ cells were rarely found in the inter-
subscapular brown adipose tissue, even in the obese mice. Thus, 
these results indicate that BMDCPCs do not transdifferentiate 
into either unilocular and multilocular adipocytes in adult adi-
pose tissues under normal or obese conditions.
Rosiglitazone treatment does not induce trans-
differentiation of BMDCPCs into multilocular 
adipocytes in adipose tissues. Crossno et al. 
(25) also reported that treatment with the 
pharmacological PPARγ activator rosi-
glitazone (ROSI) promoted transdiffer-
entiation of BMDCPCs into multilocular 
adipocytes in the adipose tissues, ranging 
from 15% to 30% of total adipocytes. We 
performed the ROSI treatment with the 
same regimen (about 15 mg/kg/d for 4 
weeks) to examine whether GFP+perilipin+ 
multilocular adipocytes formed in the 
adipose tissue. However, in contrast to 
the report of Crossno et al. (25), none of 
the GFP+ cells were perilipin+ multilocular 
adipocytes in epididymal (~40,000 adipo-
cytes), mesenteric (~24,000 adipocytes), 
retroperitoneal (~16,000 adipocytes), sub-
cutaneous (~40,000 adipocytes), dermal 
(~4,000 adipocytes), or intersubscapular 
brown (~8,000 adipocytes) adipose tissues 
of the ROSI-treated mice (n = 4; Figure 5, 
A and B). Intriguingly, the most unilocular 
adipocytes were instead in the epididymal, 
mesenteric, retroperitoneal, and subcuta-
neous tissues, but not in the dermal tis-
sue; adipose tissues converted to the mul-
tilocular adipocytes (Figure 5, A and B). 
Similar to the Crossno et al. report (25), 
we sometimes observed numbers of mas-
sively clustered GFP+ cells, but dissecting 
image analysis of these cells by confocal 
microscopy revealed that they were not GFP+perilipin+ multilocu-
lar adipocytes (Figure 5, C and D). Thus, the ROSI treatment did 
not induce transdifferentiation of BMDCPCs into multilocular 
adipocytes, although it massively induced a distinctive adipocyte 
multilocularization in several adipose tissues.
Figure 4
No GFP+perilipin+ unilocular and multilocu-
lar adipocytes were detected in the adi-
pose tissues of mice fed normal or high-fat 
diet. Adipose tissues were harvested from 
C57BL/6J mice that had received BMT 
from GFP+ mice 2 months previously and 
were then fed a normal diet (A) or a high-
fat diet (B) for the 2-month period. Tissues 
were whole-mounted, coimmunostained for 
perilipin and collagen IV (which surrounds 
each adipocyte individually as the basement 
membrane), and merged. White arrowheads 
in A indicate typical multilocular adipocytes. 
In B, there are 2 kinds of clustered GFP+ 
cells: GFP+perilipin– collagen IV+ cells (pink 
arrowheads) and GFP+perilipin–collagen IV– 
cells (yellow arrowheads). Note that no GFP+ 
cells were perilipin+ multilocular or unilocular 
adipocytes. BF, intersubscapular brown fat. 
Scale bars: 50 μm (A, top 3 rows); 20 μm (A, 
bottom row); 100 μm (B).
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G-CSF treatment does not induce transdifferentiation of BMDCPCs into 
multilocular adipocytes in adipose tissues. Many previous studies (30–32) 
have demonstrated that adipocytes could be generated from bone 
marrow–derived mesenchymal stem cells in vitro, and G-CSF is 
known to mobilize both hematopoietic stem cells and mesenchymal 
stem cells (33, 34) from the bone marrow. For these reasons, we 
assessed any transdifferentiation of BMDCPCs into GFP+perilipin+ 
adipocytes in the adipose tissues of the mice, which were treated 
with G-CSF (10 μg/kg/d intraperitoneally for 2 weeks). However, 
none of the GFP+ cells were perilipin+ multilocular adipocytes in 
epididymal (~30,000 adipocytes), mesenteric (~18,000 adipocytes), 
retroperitoneal (~10,000 adipocytes), subcutaneous (~30,000 adi-
pocytes), or intersubscapular brown (~6,000 adipocytes) adipose 
tissues of the G-CSF–treated mice (n = 3) (Supplemental Figure 7). 
These data indicate that G-CSF–induced enhanced mobilization of 
bone marrow–derived mesenchymal stem cells into BMDCPCs does 
not change with the nontransdifferentiation of BMDCPCs into adi-
pocytes in several adipose tissues in vivo.
BMDCPCs do not transdifferentiate into adipocytes in regrowing adipose 
tissues and wound-healing dermal tissue. We next addressed the com-
mitment, if any, of BMDCPCs to transdifferentiate into adipocytes 
in adipose tissues during regrowth. To create a model of regrowing 
adipose tissue, we dissected the proximal portion (20% of the total 
length) of the left-side epididymal adipose tissue (Figure 6, A and 
E), and the mice were fed normal or high-fat diet for 2 months 
following the dissection. Mice fed the high-fat diet exhibited an 
enhanced regrowth that was approximately 32.7% more than that 
of the mice fed the normal diet (n = 4 per group). Nevertheless, 
even in the mice fed the high-fat diet, no GFP+ cells were perilipin+ 
adipocytes in any area, including the regrowth and central regions 
of the left-side epididymal adipose tissue at 2 weeks and 4 months 
following dissection (Figure 6, B and F–I). In fact, several (~15 of 
Figure 5
No GFP+perilipin+ unilocular and multilocular adipocytes were detected in the adipose tissues of mice treated with ROSI. Adipose tissues were 
harvested from C57BL/6J mice that had received BMT from GFP+ mice 2 months previously and then were treated with ROSI (~15 mg/kg/d) 
for 4 weeks. Tissues were whole-mounted, coimmunostained for perilipin and collagen IV (which surrounds each adipocyte individually as the 
basement membrane), and merged. (A and B) No GFP+perilipin+ unilocular and multilocular adipocytes were detected in the adipose tissues. 
Higher-magnifications views of the merged images in A revealed characteristic GFP–perilipin+ multilocular adipocytes (B). (C and D) Massively 
clustered GFP+ cells were seen in epididymal fat, but sequential dissected images of the boxed region in C revealed that no GFP+ cells were 
perilipin+ adipocytes (D). Scale bars: 100 μm (A and C); 50 μm (B).
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40,000 adipocytes) GFP+ cells that were similar to unilocular adi-
pocytes were detected in the regrowing region at 2 weeks after the 
dissection (Figure 6, B and C), but dissecting image analysis of 
these cells revealed that they were not GFP+ unilocular adipocytes, 
but rather clustered GFP+ macrophages and leukocytes.
We also assessed the commitment, if any, of BMDCPCs to trans-
differentiate into adipocytes in adult dermal tissues during skin 
wound healing. To create a dermal wound healing model, we made 
hole-punch injuries to the ears of adult mice (Figure 6, J and O) and 
fed them with the normal and high-fat diets as described above. 
Nevertheless, even in the high-fat diet–fed mice, no GFP+ cells were 
perilipin+ adipocytes in any area, including the wound-healing and 
adjacent normal regions of the ear skin at 2 weeks and 2 months 
after the induced injury (n = 3 per group; Figure 6, K–N and P–S). 
In fact, many bone marrow–derived GFP+ cells were detected in the 
healing region at 2 weeks after the injury. However, the number of 
GFP+ cells was markedly reduced and the healing region replaced 
with scar tissue over time (Figure 6, K and P). These results indi-
cate that BMDCPCs do not transdifferentiate into adipocytes in 
regrowing adipose tissue and wound-healing dermal tissue.
Bone marrow cells transdifferentiate into multilocular adipocytes 
in vitro, but not in vivo. The above results raised the question of 
whether the GFP+ cells in the recipient bone marrow could trans-
differentiate into adipocytes. To examine this possibility, we iso-
lated the GFP+ cells from the recipient bone marrow and cultured 
them in control or adipogenic medium for 5 days or mixed with 
Figure 6
No GFP+perilipin+ adipocytes were detected in regenerative adipose tissues and wound-healing dermal tissue. (A–I) A proximal portion (20% of 
the total length) of the left-side epididymal adipose tissue of 8-week-old C57BL/6J mice that had received BMT from GFP+ mice 2 months before 
the dissection (dotted lines, A and E). The mice were fed a high-fat diet for the indicated periods. (B–D and F–I) Both sides of the epididymal 
adipose tissue from the mice were harvested, photographed, and immunostained for perilipin (red stain) and PECAM-1 (blue stain) of the dis-
sected region of the left epididymal adipose tissue (A and E, boxed regions). Some clustered GFP+ cells (green stain) looked like unilocular 
adipocytes (B and C), but the sequential dissected images of this portion (boxed region in C) revealed smaller and clustered GFP+perilipin– cells 
(D). No GFP+perilipin+ adipocytes were detected in the adipose tissues. (J–S) Hole-punch injuries made in the ears of 8-week-old C57BL/6J 
mice that had received BMT from GFP+ mice 2 months before and were then fed a high-fat diet for the indicated times. Ears from the mice were 
harvested and photographed, and immunostained for perilipin and PECAM-1 at the healing region of ear (J and O, boxed regions). (K–N and 
P–S) No GFP+ cells were perilipin+ adipocytes in the wound-healing dermal tissues after the injury. Scale bars: 100 μm.
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Matrigel and implanted into the flank region subcutaneously. The 
cultured GFP+ cells formed small lipid droplet–containing multi-
locular, but not unilocular, adipocytes in the adipogenic medium 
(Figure 7A), whereas they did not form lipid droplet–containing 
cells in the control medium. At 2 weeks after the implantation, 
no GFP+perilipin+ adipocytes were found in the Matrigel (Figure 
7B). In contrast, stromal vascular cells (SVCs) from epididymal 
adipose tissue of GFP+ mice became unilocular adipocytes in the 
Matrigel at 2 weeks after the implantation (Figure 7B). These data 
clearly indicate that bone marrow stem cells rarely become adi-
pocytes in vivo. To test whether bone marrow stem cells per se 
have no adipogenic potential in vivo, we directly implanted GFP+ 
bone marrow cells into the epididymal adipose tissue, foot pad, 
and intradermal region of the ear skin of adult normal mice. The 
shapes of implanted GFP+ bone marrow cells changed, and the 
numbers of cells were markedly reduced over time (Figure 7C). 
However, none of the GFP+ cells were either unilocular or multi-
locular adipocytes in epididymal adipose tissue (~30,000 adipo-
cytes from 3 mice), food pad (~3,000 adipocytes from 3 mice), or 
ear skin (~3,000 adipocytes from 3 mice; Figure 7C). These results 
clearly indicate that bone marrow cells do not transdifferentiate 
into adipocytes under any conditions or in any tissues in vivo.
Evidence that GFP+ circulating cells do not transdifferentiate into adipocytes 
of the adult adipose tissues in the parabiosis model. To confirm the inabil-
ity of BMDCPCs to transdifferentiate into adipocytes in the BMT 
model, we assessed the commitment, if any, of BMDCPCs to trans-
differentiate into adipocytes in adult adipose tissues using a parabio-
sis model (35). Consistent with previous reports (36), cross-circula-
tion was established by day 3 after the parabiosis surgical joining, as 
evidenced by the fact that GFP+ cells were detected in several organs, 
Figure 7
Bone marrow cells transdifferentiated into multilocular adipocytes in vitro, but not in vivo. Approximately 3 × 105 GFP+ cells from bone marrow of 
GFP+ mice were cultured in the adipogenic medium for 5 days (A), mixed with Matrigel and implanted into the flank region subcutaneously (B), 
or directly implanted into the epididymal adipose tissue, foot pad, and intradermal region of ear skin (C) of 8-week-old C57BL/6J mice. (B) As a 
positive control, about 3 × 105 GFP+ SVCs from the epididymal adipose tissue of the GFP+ mice were mixed with the Matrigel and implanted into 
the flank region subcutaneously. (A) The cultured cells were stained with Oil red and hematoxylin, and the images were captured by brightfield, 
fluorescence, and phase-contrast microscopy and merged. After 2 weeks (B) or the indicated time periods (C), the gels and tissues implanted 
with the GFP+ cells were harvested, whole-mounted, and immunostained for perilipin (red stain). No GFP+perilipin+ unilocular adipocytes were 
detected in the gel containing GFP+ (green stain) bone marrow cells, while many GFP+perilipin+ unilocular adipocytes were detected in the gel 
containing GFP+ SVCs. The shapes of the implanted GFP+ bone marrow cells in the indicated tissues had changed, and the numbers of the 
cells were markedly reduced over time. No GFP+perilipin+ adipocytes were detected in the cells. In C, blue stain denotes PECAM-1. Scale bars: 
25 μm (A); 100 μm (B and C).
research article
3692	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 117   Number 12   December 2007
including the adipose tissue and skin dermal tissue (Supplemental 
Figure 8). We examined GFP+ cells in the adipose tissues of GFP– mice 
transplanted through parabiosis for 2 weeks with GFP+ BMDCPCs 
from GFP+ mice (Figure 8A). None of the GFP+ cells were unilocular 
or multilocular adipocytes in epididymal (~30,000 adipocytes from 3 
mice; Figure 8B), mesenteric (~18,000 adipocytes from 3 mice), retro-
peritoneal (~12,000 adipocytes from 3 mice), subcutaneous (~30,000 
adipocytes from 3 mice), or dermal (~3,000 adipocytes from 3 mice) 
adipose tissues. Most GFP+ cells were CD11b+ macrophages and 
CD45+ leukocytes in the adipose tissues (Figure 8B). Clustered GFP+ 
cells were often detected (Figure 8B), but these cells were neither mul-
tilocular adipocytes nor unilocular adipocytes. In comparison, bone 
marrow–derived GFP+ cells were largely detected in spleen and rarely 
detected in lung, liver, or kidney as macrophages or lymphocytes 
(Figure 8C). These results confirm that circulating stem cells do not 
contribute to form adipocytes in adult adipose tissues.
Discussion
Our results clearly demonstrated that BMDCPCs did not trans-
differentiate into either unilocular or multilocular adipocytes in 
any normal adipose tissues or in the obese, ROSI-induced mul-
tilocularized, and regrowing adipose tissues. We adopted a BMT 
model transplanted with GFP+ bone marrow cells to investigate 
whether BMDCPCs could transdifferentiate into adipocytes of 
adult adipose tissues. Visualization of genetically tagged GFP+ 
cells in whole-mounted adipose tissues using confocal microsco-
py provided an unambiguous visualization of the cell shapes and 
localization of BMDCPCs in the multicellular adipose tissues. 
Moreover, the addition to the whole-mounted adipose tissues of 
immunostaining for perilipin and collagen IV is critical and of 
paramount importance for assessing the presence or absence of 
GFP+perilipin+ transdifferentiated unilocular and multilocular 
adipocytes in the adipose tissues. Because perilipin is found exclu-
sively on the outer surface of lipid storage droplets in every adipo-
cyte (26), the visualization of perilipin by specific immunostaining 
clearly distinguished adipocytes from nonadipocytes in multicel-
lular adipose tissues. Moreover, because collagen IV surrounds 
each individual adipocyte as a basement membrane (29), the visu-
alization of collagen IV and perilipin by coimmunostaining clearly 
distinguished multilocular adipocytes from unilocular adipocytes. 
Figure 8
No GFP+perilipin+ adipocytes were detected in the adipose tissues of the parabiosis mouse. (A) The parabiosis between GFP+ and GFP– C57BL/
6J mice was conducted, with the animals remaining alive for 2 weeks with a normal diet. (B and C) The indicated tissues were harvested, whole-
mounted, coimmunostained for perilipin (red stain) and CD45 or CD11b (blue stain, B) or perilipin and PECAM-1 (blue stain, C), and merged. No 
GFP+ cells were perilipin+ adipocytes in the adipose tissues, and clustered GFP+CD45+ macrophages were detected (white arrowheads). The 
GFP+ cells (green stain) were largely detected in spleen. Scale bars: 100 μm.
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Using these reliable and convincing visualization methods, despite 
examining more than 900,000 adipocytes in the different adipose 
tissues, we found no compelling evidence that any of these GFP+ 
BMDCPCs transdifferentiated into either unilocular or multilocu-
lar perilipin+ adipocytes regardless of their location in the normal, 
obese, ROSI-treated, or G-CSF–treated mice, even in regrowing or 
wound-healing adipose tissues. Although adipophilin is known to 
be expressed ubiquitously in adipose tissue (26–28), our histologi-
cal analyses revealed that only a certain subpopulation of small-
sized adipocytes uniquely and strongly expressed adipophilin in 
these tissues. These additional findings enabled us to confirm that 
none of the GFP+ BMDCPCs transdifferentiated into adipophilin+ 
adipocytes in the adipose tissues of the normal and obese mice. We 
also confirmed these results with the parabiosis model.
Our findings are in marked contrast to those of Crossno et al. (25), 
who recently reported that BMDCPCs could transdifferentiate into 
multilocular, but not unilocular, adipocytes in the adipose tissues. 
They adopted a BMT model similar to the one we used: donor bone 
marrow cells from the transgenic mice that express GFP+ on a uni-
versal promoter and subjected them to similar protocols of a high-
fat diet and the ROSI treatment. With this model, the authors found 
that BMDCPCs transdifferentiated into multilocular adipocytes and 
that these cells constituted approximately 7%–17% and 15%–30% of 
total cells in the adipose tissues of the high-fat diet–induced obese 
and ROSI-treated mice; these cells constituted about 2%–7% of total 
cells in the adipose tissues of the normal mice. However, their con-
clusions were based entirely on data derived from flow cytometric 
analysis of adipocyte suspensions and sectioned adipose tissues for 
assessment of the GFP+ cells, without coimmunostaining of perili-
pin, collagen IV, or macrophage markers. Thus, they may not have 
clarified the identity of the “bunch” shape of clustered GFP+ cells 
(25) and “adipocyte-like” clustered GFP+ macrophages adequately 
and accurately in the adipose tissues.
Throughout our assessments, we observed approximately 1,000 
clustered adipocyte-like GFP+ cells in the adipose tissues of obese, 
ROSI-treated, and G-CSF–treated mice and in regrowing adipose 
tissue. Dissecting image analysis of these cells by confocal micros-
copy, however, revealed that these cells were clustered GFP+ macro-
phages rather than GFP+ adipocytes. Interestingly, these clustered 
GFP+ macrophages strongly expressed F4/80, expressed CD45 and 
CD11b to a lesser extent, and expressed LYVE-1 at low levels. How-
ever, Crossno et al. (25) likely interpreted these clustered adipocyte-
like GFP+ macrophages as GFP+ multilocular adipocytes. The clus-
tered macrophages in obese adipose tissues are known to be active 
phagocytic macrophages on dead adipocytes (37). In this regard, 
F4/80+ macrophages could have more enhanced phagocytic activ-
ity than do LYVE-1+ macrophages. It is known that increased infil-
tration of F4/80+ and CD11b+ macrophages in the adipose tissue 
contributes to the development of metabolic syndrome (38–40). We 
recently found that LYVE-1+ macrophages in the tip region of epi-
didymal adipose tissue have an angiogenic role (41). Thus, macro-
phages expressing different markers may have different functions 
in the adipose tissue. It is intriguing to note that pharmacological 
activation of PPARγ with ROSI induced marked and characteristic 
multilocularization of adipocytes in most white adipose tissues. 
Adipocyte multilocularization can be found in special situations 
such as β3-adrenergic stimulation (42, 43), exposure to cold tem-
perature (44), or deletion of translational inhibitor 4E-BP1 (45). 
Although the underlying mechanism that creates the adipocyte 
multilocularization by the ROSI treatment and the significance of 
adipocyte multilocularization in regulation of lipid storage remain 
unclear, the multilocularization process occurs from unilocular 
adipocytes within adipose tissue, but not outside of it.
Consistent with a wealth of previous findings (30, 46, 47), our 
study shows that in vitro cultured GFP+ progenitor cells from bone 
marrow can transdifferentiate into multilocular, but not into uni-
locular, adipocytes in adipogenic medium. In contrast, however, 
we found no compelling evidence that bone marrow stem cells 
per se transdifferentiate into adipocytes in the implanted Matri-
gel or in tissues into which they were directly implanted. More-
over, even though the BMDCPCs contained more mobilized bone 
marrow–derived mesenchymal stem cells due to the G-CSF treat-
ment, there was no transdifferentiation of BMDCPCs into adi-
pocytes in the adipose tissues in vivo. In comparison, the SVCs 
derived from GFP+ mice differentiated into unilocular adipocytes 
in the implanted Matrigel. Thus, BMDCPCs could have adipo-
genic potential in vitro in a highly calorie-preserving adipogenic 
medium, but not in any situations in vivo. To date, controversial 
findings from one extreme to the other are still appearing as to 
whether BMDCPCs can give rise to cardiomyocytes (20, 21, 48), 
smooth muscle (22), skeletal muscle (15), vascular endothelial 
cells (17, 18), renal tubular epithelial cells (49), kidney mesangial 
cells (19), hepatocytes (16), or cardiac valve interstitial cells (23) in 
pathologic and regenerative tissues in vivo. Thus, BMDCPCs may 
or may not give rise many different resident cells in every organ, 
ranging from differentiated to undifferentiated cells, depending 
on the microenvironment. One rare case of reverse adipocyte-to-
epithelium transdifferentiation takes place in the mammary gland 
of adult mice during pregnancy and lactation (50).
Regardless of findings in other tissues, our results indicate that 
BMDCPCs do not give rise any differentiated resident adipocytes, 
even in regenerative adipose tissues and wound-healing dermal tis-
sue. These results have led to some intriguing questions. It is still 
unknown whether there are any determined adipocyte stem cells or 
progenitors in bone marrow, which can be properly mobilized by 
certain stimuli into systemic circulation to become adipoblasts or 
preadipocytes via transdifferentiation triggered by further appro-
priate stimuli. If these cells do exist in bone marrow, do adipose 
tissues provide an unfavorable environment for their homing or 
transdifferentiation? To address this hypothesis, we need to iden-
tify selective markers that can distinguish adipoblasts or preadipo-
cytes in bone marrow, circulating blood, and adipose tissues.
Finally, the parabiosis model used in this study confirmed that 
BMDCPCs cannot transdifferentiate into adipocytes. This model 
circumvented the disadvantages of the BMT model regarding the 
age of the mice, possible loss of mesenchymal stem cell repopula-
tion in bone marrow, and unavoidable radiation injury on bone 
marrow. The age of the mice receiving BMT was relatively high at 
6–8 months of age when the adipose tissues were analyzed after 
several treatments; therefore, the transdifferentiation capability of 
BMDCPCs could have been markedly reduced. However, the age of 
the mice receiving parabiosis was only 2–3 months when the adi-
pose tissues were analyzed. In the BMT model, it is possible that 
a number of mesenchymal stem cells responsible for adipocyte 
stem cells could be reduced in bone marrow during repopulation 
by procedures of whole-body irradiation and systemic BMT. More-
over, these procedures result in improper mobilization of adipo-
genic bone marrow stem cells from bone marrow. In comparison, 
in the parabiosis model, intact donor BMDCPCs derived from the 
intact bone marrow are directly circulated into syngeneic recipient 
research article
3694	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 117   Number 12   December 2007
circulation, homing to several organs including adipose tissues. 
Nevertheless, using this parabiosis model, we found no compelling 
evidence that BMDCPCs can transdifferentiate into adipocytes.
Taken together, our results provide evidence that BMDCPCs do 
not transdifferentiate into either unilocular or multilocular adipo-
cytes in the adipose tissues. Therefore, based on these results, we 
conclude that BMDCPCs play a negligible role in expanding the 
number of adipocytes in the growth of adipose tissues.
Methods
Mice. Specific pathogen–free C57BL/6J (C57BL/6J genetic background) 
mice were purchased from The Jackson Laboratory. GFP+ mice (C57BL/6J 
genetic background) were a gift from M. Okabe (Osaka University, Osaka, 
Japan). Mice were bred in our pathogen-free animal facility, and male mice 
aged about 8–9 weeks were used for this study unless otherwise indicated. 
Animal care and experimental procedures were performed under approval 
from the Animal Care Committees of KAIST and Dankook University. All 
animals were fed a standard normal diet (PMI LabDiet; Purina Mills Inc.) 
ad libitum with free access to water.
Isolation of bone marrow cells and BMT. Bone marrow cells (2 × 106) were har-
vested from the femurs and tibias of GFP+ mice by flushing with ice-cold 
Dulbecco’s PBS (DPBS; Sigma-Aldrich). The recipient mice (C57BL/6J), 
8 weeks old, were sublethally irradiated at a dose of 4.5 Gy with a gamma irra-
diator (Gammacell 3000; MDS Nordion Inc.). Bone marrow cells were then 
injected intravenously into the recipient mice 16 hours after irradiation. The 
indicated tissues of BMT mice were examined at the indicated times (41).
Treatments. All treatments were performed at approximately 2 months 
after BMT. For studies of obesity induced by a high-fat diet, mice were 
fed with a high-fat diet (34.9%, wt/wt, catalog no. D12492; Research Diets 
Inc.) for the 2-month period. For ROSI treatment, the mice were fed nor-
mal diet food containing ROSI (SmithKline Beecham Pharmaceuticals) ad 
libitum (15 mg/kg/d) for 4 weeks. To further mobilize mesenchymal stem 
cells from bone marrow to BMDCPCs, the mice were treated with G-CSF 
(intraperitoneal injection, 10 μg/kg/d; Choongwae Pharma Corporation) 
for 2 weeks. To develop a regenerative adipose tissue model, we anesthe-
tized the mice by intramuscular injection of a combination of anesthetics 
(80 mg/kg ketamine and 12 mg/kg xylazine) and dissected without macro-
scopic bleeding the proximal portion (20% of the total length) of the left-
side epididymal adipose tissue. To produce a regenerative dermal tissue 
model, we made a 2.0-mm hole in the center of both ears of each mouse 
using a metal ear punch (Harvard Apparatus) (51).
Mesenchymal stem cell isolation and culture. Bone marrow was collected from 
8- to 10-week-old C57BL/6 and GFP+ mice by flushing femurs and tib-
ias with ice-cold DPBS (Sigma-Aldrich). The cells were then washed twice 
in complete medium (52) consisting of DMEM–low glucose (Cambrex), 
2 mM l-glutamine, 10% fetal bovine serum (Hyclone), and penicillin/strep-
tomycin (5 U/ml; Invitrogen) and plated on a Petri dish at a density of 
2 × 106 cells/cm2. After 5 days, nonadherent cells were removed by 2–3 
washes with DPBS and adherent cells further cultured in the complete 
medium. The cultured mesenchymal stem cells were differentiated into 
adipocytes using the Mesenchymal Stem Cell Adipogenesis Kit (Chemicon 
International Inc.) according to the manufacturer’s instructions.
Implantation of bone marrow cells and SVCs. Bone marrow cells and SVCs 
from epididymal adipose tissue were harvested from GFP+ mice as previ-
ously described (41). Briefly, to obtain SVCs, the tip portion of epididymal 
adipose tissue (41) was harvested and incubated with Hanks’ balanced salts 
solution (Sigma-Aldrich) containing 0.2% type 2 collagenase (Worthing-
ton) for 1 hour at 37°C. After inactivation of collagenase activity with 
bovine serum, the cell suspension was filtered through a 100-μm nylon fil-
ter (BD Biosciences) and centrifuged at 400 g for 5 min. The floating adipo-
cytes were separated from pelleted SVCs, and both cell types were washed 
and resuspended with DPBS. Lack of perilipin+-differentiated adipocytes 
in the suspended SVCs was confirmed by immunofluorescence staining. A 
total of 3 × 105 bone marrow cells or SVCs were mixed with Matrigel (100 
μl; BD Biosciences) and implanted into the flank region subcutaneously 
and directly implanted into the epididymal adipose tissue, foot pad, and 
intradermal region of the ear skin of 8-week-old C57BL/6J mice.
Parabiosis model. Pairs of 6- to 10-week-old wild-type and GFP+ mice were 
subjected to parabiotic surgery. Mice were anesthetized by intramuscular 
injection of the combination of anesthetics (80 mg/kg ketamine and 12 
mg/kg xylazine), then surgically joined from shoulder to femur. At the 
indicated number of weeks after parabiotic surgery, GFP+ cells in the adi-
pose tissues of wild-type mice were examined.
Histological and morphometric analysis. Mice were anesthetized by intra-
muscular injection of the combination of anesthetics, and adipose tis-
sues were fixed by vascular perfusion of 1% paraformaldehyde in PBS and 
whole-mounted or cryo-embedded and sectioned. Whole-mount tissues 
and cryosections (20 μm thickness) were prepared and incubated for 1 h 
at room temperature with blocking solution containing 5% goat serum 
(Jackson ImmunoResearch Laboratories Inc.) in PBST (0.3% Triton X-100 
in PBS). After blocking, the whole-mounted tissues and cryosections were 
incubated overnight at 4°C with one or more of the following primary 
antibodies: (a) for adipocytes, guinea pig anti-perilipin antibody (diluted 
1:1,000; Research Diagnostics) and guinea pig anti-adipophilin antibody 
(diluted 1:1,000; Research Diagnostics); (b) for blood vessels, hamster 
anti–PECAM-1 antibody (clone 2H8, diluted 1:1,000; Chemicon Inter-
national); (c) for macrophages and leukocytes, rat anti-mouse CD11b 
antibody (clone M1/70, diluted 1:1,000; BD Biosciences — Pharmingen), 
rat anti-mouse F4/80 antibody (clone Cl:A3-1, diluted 1:1,000; Serotec), 
rat anti-mouse LYVE-1 antibody (clone Han-1, diluted 1:1,000; Aprogen), 
and rat anti-mouse CD45 (clone 30-F11, diluted 1:1,000; BD Biosciences 
— Pharmingen); and (d) for basement membrane of individual adipocytes, 
rabbit anti-collagen IV antibody (diluted 1:1,000; Cosmo Bio Co. Ltd.). 
After several washes in PBST, whole-mounted tissues and cryosections 
were incubated for 1 h at room temperature with one or more secondary 
antibodies: (a) Cy3- or Cy5-conjugated anti-guinea pig antibody (Jackson 
ImmunoResearch Laboratories); (b) Cy3- or Cy5-conjugated anti-rat anti-
body or anti-rabbit antibody (diluted 1:500; Jackson ImmunoResearch 
Laboratories); or (c) Cy3- or Cy5-conjugated anti-hamster IgG antibody 
(diluted 1:500; Jackson ImmunoResearch Laboratories). For control exper-
iments, the primary antibody was omitted or substituted with preimmune 
serum. Signals were visualized, and digital images were obtained using 
a Zeiss ApoTome microscope and a Zeiss LSM 510 confocal microscope 
equipped with argon and helium–neon lasers (Carl Zeiss). For determining 
the GFP+ unilocular and multilocular adipocytes, double-immunostained 
color images for perilipin and collagen IV were captured with a Zeiss LSM 
510 confocal microscope. Using ImageJ software (http://rsb.info.nih.
gov/ij), we selected the clustered GFP+ area as a region of interest from 
macrophage/GFP+-stained images, and macrophage/GFP+-stained images 
were converted to 8-bit gray scale. Area densities of the macrophage/GFP+-
stained images were measured from the pixels in the region of interest; 
only pixels exceeding a certain level (>50 intensity value) were taken to 
exclude background fluorescence.
Statistics. Values presented are means ± SD. Significant differences between 
means were determined by analysis of variance followed by the Student-
Newman-Keuls test. Statistical significance was set at P < 0.05 or P < 0.01.
Acknowledgments
This work was supported by the Korea Science and Engineering 
Foundation (KOSEF) through the National Research Laboratory 
research article
	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 117   Number 12   December 2007 3695
Program (2004-02376 to G.Y. Koh) funded by the Ministry of Sci-
ence and Technology.
Received for publication April 25, 2007, and accepted in revised 
form September 19, 2007.
Address correspondence to: Gou Young Koh, Department of Bio-
logical Sciences, KAIST, 373-1, Guseong-dong, Daejeon, 305-701, 
Republic of Korea. Phone: 82-42-869-2638; Fax: 82-42-869-2610; 
E-mail: gykoh@kaist.ac.kr.
 1. Greenberg, A.S., and Obin, M.S. 2006. Obesity and 
the role of adipose tissue in inflammation and 
metabolism. Am. J. Clin. Nutr. 83:461S–465S.
 2. Shoelson, S.E., Lee, J., and Goldfine, A.B. 2006. 
Inflammation and insulin resistance. J. Clin. Invest. 
116:1793–1801.
 3. Martin, R.J., Hausman, G.J., and Hausman, D.B. 
1998. Regulation of adipose cell development in 
utero. Proc. Soc. Exp. Biol. Med. 219:200–210.
 4. Hausman, D.B., DiGirolamo, M., Bartness, T.J., 
Hausman, G.J., and Martin, R.J. 2001. The biology of 
white adipocyte proliferation. Obes. Rev. 2:239–254.
 5. Rosen, E.D., and MacDougald, O.A. 2006. Adipo-
cyte differentiation from the inside out. Nat. Rev. 
Mol. Cell Biol. 7:885–896.
 6. Schutz, Y. 2004. Dietary fat, lipogenesis and energy 
balance. Physiol. Behav. 83:557–564.
 7. Crandall, D.L., Hausman, G.J., and Kral, J.G. 1997. 
A review of the microcirculation of adipose tissue: 
anatomic, metabolic, and angiogenic perspectives. 
Microcirculation. 4:211–232.
 8. Hausman, G.J., and Richardson, R.L. 1983. Cellular 
and vascular development in immature rat adipose 
tissue. J. Lipid Res. 24:522–532.
 9. Zuk, P.A., et al. 2002. Human adipose tissue is 
a source of multipotent stem cells. Mol. Biol. Cell. 
13:4279–4295.
 10. Cousin, B., Andre, M., Arnaud, E., Penicaud, L., and 
Casteilla, L. 2003. Reconstitution of lethally irra-
diated mice by cells isolated from adipose tissue. 
Biochem. Biophys. Res. Commun. 301:1016–1022.
 11. Prunet-Marcassus, B., et al. 2006. From heterogene-
ity to plasticity in adipose tissues: site-specific dif-
ferences. Exp. Cell Res. 312:727–736.
 12. Cinti, S. 2001. The adipose organ: morphologi-
cal perspectives of adipose tissues. Proc. Nutr. Soc. 
60:319–328.
 13. Cinti, S. 2005. The adipose organ. Prostaglandins 
Leukot. Essent. Fatty Acids. 73:9–15.
 14. Faust, I.M., Johnson, P.R., Stern, J.S., and Hirsch, 
J. 1978. Diet-induced adipocyte number increase 
in adult rats: a new model of obesity. Am. J. Physiol. 
235:E279–E286.
 15. Camargo, F.D., Green, R., Capetanaki, Y., Jackson, 
K.A., and Goodell, M.A. 2003. Single hematopoi-
etic stem cells generate skeletal muscle through 
myeloid intermediates. Nat. Med. 9:1520–1527.
 16. Dalakas, E., Newsome, P.N., Harrison, D.J., and 
Plevris, J.N. 2005. Hematopoietic stem cell traffick-
ing in liver injury. FASEB J. 19:1225–1231.
 17. Jackson, K.A., et al. 2001. Regeneration of ischemic 
cardiac muscle and vascular endothelium by adult 
stem cells. J. Clin. Invest. 107:1395–1402.
 18. Kinnaird, T., Stabile, E., Burnett, M.S., and Epstein, 
S.E. 2004. Bone-marrow-derived cells for enhanc-
ing collateral development: mechanisms, animal 
data, and initial clinical experiences. Circ. Res. 
95:354–363.
 19. Masuya, M., et al. 2003. Hematopoietic origin of 
glomerular mesangial cells. Blood. 101:2215–2218.
 20. Orlic, D., et al. 2001. Mobilized bone marrow 
cells repair the infarcted heart, improving func-
tion and survival. Proc. Natl. Acad. Sci. U. S. A. 
98:10344–10349.
 21. Pittenger, M.F., and Martin, B.J. 2004. Mesenchymal 
stem cells and their potential as cardiac therapeu-
tics. Circ. Res. 95:9–20.
 22. Sata, M., et al. 2002. Hematopoietic stem cells 
differentiate into vascular cells that participate 
in the pathogenesis of atherosclerosis. Nat. Med. 
8:403–409.
 23. Visconti, R.P., et al. 2006. An in vivo analysis of 
hematopoietic stem cell potential: hematopoietic 
origin of cardiac valve interstitial cells. Circ. Res. 
98:690–696.
 24. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., 
and Nishimune, Y. 1997. ‘Green mice’ as a source of 
ubiquitous green cells. FEBS Lett. 407:313–319.
 25. Crossno, J.T., Jr.  Majka, S.M., Grazia, T., Gill, R.G., 
and Klemm, D.J. 2006. Rosiglitazone promotes 
development of a novel adipocyte population from 
bone marrow-derived circulating progenitor cells. 
J. Clin. Invest. 116:3220–3228.
 26. Londos, C., Sztalryd, C., Tansey, J.T., and Kimmel, 
A.R. 2005. Role of PAT proteins in lipid metabo-
lism. Biochimie. 87:45–49.
 27. Robenek, H., Robenek, M.J., and Troyer, D. 2005. 
PAT family proteins pervade lipid droplet cores.  
J. Lipid Res. 46:1331–1338.
 28. Wolins, N.E., et al. 2005. S3-12, Adipophilin, and 
TIP47 package lipid in adipocytes. J. Biol. Chem. 
280:19146–19155.
 29. Martinez-Hernandez, A., and Amenta, P.S. 1983. 
The basement membrane in pathology. Lab. Invest. 
48:656–677.
 30. Ryden, M., et al. 2003. Functional characterization 
of human mesenchymal stem cell-derived adipo-
cytes. Biochem. Biophys. Res. Commun. 311:391–397.
 31. Bosnakovski, D., et al. 2005. Isolation and multi-
lineage differentiation of bovine bone marrow 
mesenchymal stem cells. Cell Tissue Res. 319:243–253.
 32. Zeng, L., et al. 2006. Multipotent adult progeni-
tor cells from swine bone marrow. Stem Cells. 
24:2355–2366.
 33. Kawada, H., et al. 2004. Nonhematopoietic 
mesenchymal stem cells can be mobilized and dif-
ferentiate into cardiomyocytes after myocardial 
infarction. Blood. 104:3581–3587.
 34. Fukuda, K., and Fujita, J. 2005. Mesenchymal, but 
not hematopoietic, stem cells can be mobilized and 
differentiate into cardiomyocytes after myocardial 
infarction in mice. Kidney Int. 68:1940–1943.
 35. Wagers, A.J., Sherwood, R.I., Christensen, J.L., and 
Weissman, I.L. 2002. Little evidence for develop-
mental plasticity of adult hematopoietic stem cells. 
Science. 297:2256–2259.
 36. Wright, D.E., Wagers, A.J., Gulati, A.P., Johnson, 
F.L., and Weissman, I.L. 2001. Physiological migra-
tion of hematopoietic stem and progenitor cells. 
Science. 294:1933–1936.
 37. Cinti, S., et al. 2005. Adipocyte death defines macro-
phage localization and function in adipose tissue of 
obese mice and humans. J. Lipid Res. 46:2347–2355.
 38. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, 
M., Leibel, R.L., and Ferrante, A.W., Jr. 2003. Obe-
sity is associated with macrophage accumulation 
in adipose tissue. J. Clin. Invest. 112:1796–1808.
 39. Wellen, K.E., and Hotamisligil, G.S. 2003. Obesity-
induced inflammatory changes in adipose tissue.  
J. Clin. Invest. 112:1785–1788.
 40. Xu, H., et al. 2003. Chronic inflammation in fat plays 
a crucial role in the development of obesity-related 
insulin resistance. J. Clin. Invest. 112:1821–1830.
 41. Cho, C.H., et al. 2007. Angiogenic role of LYVE-1-
positive macrophages in adipose tissue. Circ. Res. 
100:e47–e57.
 42. Granneman, J.G., Li, P., Zhu, Z., and Lu, Y. 2005. 
Metabolic and cellular plasticity in white adipose tis-
sue I: effects of beta3-adrenergic receptor activation. 
Am. J. Physiol. Endocrinol. Metab. 289:E608–E616.
 43. Himms-Hagen, J., et al. 2000. Multilocular fat cells 
in WAT of CL-316243-treated rats derive directly 
from white adipocytes. Am. J. Physiol. Cell Physiol. 
279:C670–C681.
 44. Loncar, D., Afzelius, B.A., and Cannon, B. 1988. Epi-
didymal white adipose tissue after cold stress in rats. 
II. Mitochondrial changes. J. Ultrastruct. Mol. Struct. 
Res. 101:199–209.
 45. Tsukiyama-Kohara, K., et al. 2001. Adipose tissue 
reduction in mice lacking the translational inhibi-
tor 4E-BP1. Nat. Med. 7:1128–1132.
 46. Gimble, J.M., Zvonic, S., Floyd, Z.E., Kassem, M., and 
Nuttall, M.E. 2006. Playing with bone and fat. J. Cell. 
Biochem. 98:251–266.
 47. Hong, K.M., Burdick, M.D., Phillips, R.J., Heber, D., 
and Strieter, R.M. 2005. Characterization of human 
fibrocytes as circulating adipocyte progenitors and 
the formation of human adipose tissue in SCID 
mice. FASEB J. 19:2029–2031.
 48. Murry, C.E., et al. 2004. Haematopoietic stem cells 
do not transdifferentiate into cardiac myocytes in 
myocardial infarcts. Nature. 428:664–668.
 49. Krause, D., and Cantley, L.G. 2005. Bone marrow 
plasticity revisited: protection or differentiation in 
the kidney tubule? J. Clin. Invest. 115:1705–1708.
 50. Morroni, M., et al. 2004. Reversible transdifferen-
tiation of secretory epithelial cells into adipocytes 
in the mammary gland. Proc. Natl. Acad. Sci. U. S. A. 
101:16801–16806.
 51. Cho, C.H., et al. 2006. COMP-angiopoietin-1 pro-
motes wound healing through enhanced angio-
genesis, lymphangiogenesis, and blood flow in a 
diabetic mouse model. Proc. Natl. Acad. Sci. U. S. A. 
103:4946–4951.
 52. Tropel, P., et al. 2004. Isolation and characterisation 
of mesenchymal stem cells from adult mouse bone 
marrow. Exp. Cell Res. 295:395–406.
